Cell Therapy Potency Platform

About Partillion Bioscience

Partillion Bioscience, founded in 2020 and based in Los Angeles, is a private, pre-revenue platform company pioneering tools for functional single-cell analysis. Its award-winning Nanovial technology allows researchers to link a cell's secretory function (e.g., cytokine or antibody production) with its phenotype and genotype in a massively parallel, cost-effective format compatible with standard flow cytometers. The company is targeting the high-growth cell therapy and biologics discovery markets by providing a flexible reagent platform to improve the identification and characterization of potent therapeutic cells and antibodies.